Russian drug prices continue to demonstrate sharp increases this year

28 October 2025

Russia is facing a sharp growth of drug price these days due to a record inflation and the ever-deteriorating business environment, reports The Pharma Letter’s local correspondent.

According to official data of Russian statistics services, this year prices for drugs in the Russian market grew by about 15%, compared to the same period of last year, however, in reality the growth of price is significantly higher.

Amid the ever rising prices, local consumers are starting to save on drug purchases by switching to drugs in larger packages and searching for the cheapest deals through online pharmacy services. In fact, according to analysts, the increase in consumer prices is driven by rising operating costs for all participants in the industry: pharmacies, pharmaceutical manufacturers, and distributors.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight



More Features in Pharmaceutical